QuidelOrtho Lowers FY2026 Adj EPS Guidance from $2.00-$2.42 to $1.80-$2.00 vs $2.13 Est; Narrows FY2026 Sales Guidance from $2.700B-$2.900B to $2.700B-$2.750B vs $2.747B Est